BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. BRCA1, G-protein-coupled receptor binding, Ischemia, Stem cell, Neocentromeres)
Bookmark Forward

Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia.

Michael C Davis, Brian J Miller, Jasmeet K Kalsi, Thomas Birkner, Mitchell V Mathis

The New England journal of medicine 2017 Jun 29


filter terms:
  • dyskinesia (2)
  • food (1)
  • humans (1)
  • phase (1)
  • protein human (1)
  • slc18a2 protein, human (1)
  • transport proteins (2)
    • Sizes of these terms reflect their relevance to your search.

    No abstract available.

    Citation

    Michael C Davis, Brian J Miller, Jasmeet K Kalsi, Thomas Birkner, Mitchell V Mathis. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia. The New England journal of medicine. 2017 Jun 29;376(26):2503-2506

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28489481

    View Full Text
    • Copyright © 2024 Illumina Inc. All rights reserved.